NUVATION BIO INC's ticker is NUVB and the CUSIP is 67080N101. A total of 130 filers reported holding NUVATION BIO INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,776,851 | -25.4% | 7,296,158 | +0.2% | 0.00% | – |
| Q2 2023 | $13,102,272 | +9.6% | 7,279,040 | +1.1% | 0.00% | – |
| Q1 2023 | $11,956,094 | -37.3% | 7,202,466 | -27.5% | 0.00% | -100.0% |
| Q4 2022 | $19,070,288 | -32.7% | 9,932,441 | -21.4% | 0.00% | 0.0% |
| Q3 2022 | $28,324,000 | -30.8% | 12,644,451 | +0.1% | 0.00% | 0.0% |
| Q2 2022 | $40,930,000 | -39.8% | 12,632,638 | -2.3% | 0.00% | -50.0% |
| Q1 2022 | $68,025,000 | -28.9% | 12,932,460 | +14.8% | 0.00% | 0.0% |
| Q4 2021 | $95,715,000 | -19.1% | 11,260,552 | -5.4% | 0.00% | -33.3% |
| Q3 2021 | $118,311,000 | +14.5% | 11,902,527 | +7.3% | 0.00% | 0.0% |
| Q2 2021 | $103,307,000 | +42.1% | 11,096,361 | +59.5% | 0.00% | +50.0% |
| Q1 2021 | $72,702,000 | – | 6,957,156 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 22,957,340 | $120,756,000 | 24.71% |
| Aisling Capital Management LP | 2,541,009 | $13,366,000 | 7.21% |
| EDBI Pte Ltd | 1,270,504 | $6,683,000 | 4.45% |
| Ally Bridge Group (NY) LLC | 1,137,152 | $5,981,000 | 4.43% |
| EcoR1 Capital, LLC | 13,896,543 | $73,096,000 | 2.29% |
| Boxer Capital, LLC | 4,341,009 | $22,834,000 | 1.17% |
| Baupost Group | 10,443,494 | $54,933,000 | 0.59% |
| Redmile Group, LLC | 3,471,709 | $18,261,000 | 0.57% |
| Avidity Partners Management LP | 4,855,006 | $25,537,000 | 0.53% |
| Abrams Capital Management | 3,811,513 | $20,049,000 | 0.47% |